// App-Quantinova.ai

: Better Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning in Elderly Patients with Hematological Malignancies

Researchers

Presenter

  • Yongqiang Zhao

Principal Investigators

  • yanzhi song

  • Fan Yang

  • Feifei Li

  • Dongfang Yang

  • Tong Wu

Medical Centers

  • Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • B cell lymphomas

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • fludarabine tablet

  • Cytarabine liposomal

  • Decitabine

  • Etoposide

  • Etoposide phosphate

  • Busulfan

  • Allopurinol

  • Lomustine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved